Oflobest-MZ Oral Suspension
Images are for reference. Actual packaging may vary.
Ofloxacin (50mg) + Metronidazole (120mg) + Simethicone (10mg)
Bottle of 30 ml • Syrup
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+2 more active ingredients
Ofloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Simethicone decreases the surface tension of gas bubbles in the gastrointestinal tract, facilitating their expulsion and alleviating bloating and discomfort.
Metronidazole disrupts DNA synthesis in anaerobic bacteria and protozoa, leading to their death.
Medical applications
Oflobest-MZ Oral Suspension is a combination antibiotic formulation containing Ofloxacin (50mg), Metronidazole (120mg), and Simethicone (10mg) per dose, designed for the effective treatment of mixed bacterial infections of the gastrointestinal tract. Ofloxacin, a fluoroquinolone antibiotic, exhibits broad-spectrum activity against gram-positive and gram-negative bacteria by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication.
Metronidazole, a nitroimidazole antimicrobial agent, targets anaerobic bacteria and protozoa by disrupting DNA synthesis, making it effective against anaerobic infections commonly encountered in the gastrointestinal system. Simethicone acts as an antiflatulent agent, reducing bloating and discomfort associated with excessive gas by coalescing gas bubbles, facilitating their elimination.
This combination is indicated for the treatment of infections such as bacterial gastroenteritis, amoebic dysentery, and mixed anaerobic and aerobic bacterial infections where gas-related symptoms are present. Oflobest-MZ Oral Suspension should be administered as prescribed by a healthcare professional, with dosage adjusted according to the severity of infection and patient response.
Caution is advised in patients with hypersensitivity to fluoroquinolones or nitroimidazoles, and it is contraindicated during pregnancy and lactation unless deemed necessary. Adverse effects may include gastrointestinal disturbances, hypersensitivity reactions, and, rarely, neurological symptoms.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Oflobest-MZ Oral Suspension should be used with caution in patients with kidney disease. Dose adjustment of Oflobest-MZ Oral Suspension may be needed. Please consult your doctor.
Exercise Caution
Oflobest-MZ Oral Suspension should be used with caution in patients with severe liver disease. Dose adjustment of Oflobest-MZ Oral Suspension may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Oflobest-MZ Oral Suspension







